Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Weizhi Baike Pharmaceutical is a comprehensive pharmaceutical enterprise based in Zibo, China, focusing on the development and production of high-quality active pharmaceutical ingredients (APIs) and finished drug products. The company operates as a significant manufacturing arm within the Weizhi Group, maintaining state-of-the-art facilities that comply with international GMP standards. Its product portfolio primarily targets chronic diseases, including viral hepatitis, cardiovascular conditions, and respiratory ailments. By leveraging advanced chemical synthesis technologies, the company provides essential generic medications such as Entecavir and Rosuvastatin to global markets. Shandong Weizhi Baike is committed to pharmaceutical innovation and quality excellence to improve patient access to affordable healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Weizhi Baike Pharmaceutical.